OR WAIT null SECS
August 19, 2010
Eli Lilly Ends Semagacestat Program; Selecta Appoints CEO; And More.
August 12, 2010
Penwest and Endo to Merge; Watson Makes Senior Appointments; And More.
August 05, 2010
In a draft guidance published this week, the US Food and Drug Administration recommended that makers of transdermal and transmucosal drug-delivery systems use "an appropriate scientific approach" during product design, development, and manufacturing to minimize the amount of residual drug substance present at the end of the products' labeled use periods.
FDA Approves Flu Vaccines; Caraco Names COO; And More.
August 02, 2010
Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.
Industry can meet its responsibility to society by considering innovative pricing and partnerships.
Pharmaceutical Technology talked to experts in siRNA-drug development to gain insight into the characteristics, processes, and challenges of this class of therapeutics.
August 01, 2010
As emerging markets become increasingly important for the pharmaceutical majors, companies are re-evaluating their outsourcing strategies. This article is part of the 2010 Outsourcing Resources special issue.
The authors describe recent market trends and indicate the likely future direction of the pharmaceutical and biopharmaceutical industries. This article is part of the 2010 Outsourcing Resources special issue.
July 29, 2010
Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.